Kainos Medicine Inc (284620) — Cash Flow Reinvestment Rate
Latest as of June 2019:
0.00x
Kainos Medicine Inc (284620) has a Cash Flow Reinvestment Rate of 0.00x as of June 2019, reinvesting ₩0.00 (capex ₩0.00 ) from operating cash flow of ₩208.76 Million. See Kainos Medicine Inc balance sheet independence to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
₩0.00
Capex + Investments
Operating Cash Flow
₩208.76 Million
KRW
Capital Expenditures
₩0.00
KRW
Kainos Medicine Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Kainos Medicine Inc across 1 annual periods. Also explore 284620 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Kainos Medicine Inc (2019–2019)
Year-by-year capital reinvestment analysis for Kainos Medicine Inc. For live market cap and broader valuation context, see Kainos Medicine Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.00x | ₩0.00 | ₩185.74 Million | ₩0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow